Rejuvenating aging

What anti-aging company Juvenescence plans to do with its series A

Anti-aging company Juvenescence Ltd. is hoping to bring a total of 10 candidates from its portfolio companies and academic partnerships into the clinic over the next two years with its recent $50 million series A funding.

Announced on June 11, the oversubscribed financing saw participation from company founders and insiders, as well as undisclosed

Read the full 544 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE